Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PFE
PFE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest PFE ETF News Today | Earnings, Events & Price Alerts
PFE News
Reasons to Invest in Pfizer Stock
17h ago
Fool
PFIZER CEO CLAIMS FDA CBER DIRECTOR IS IGNORING STAFF RECOMMENDATIONS - TD COWEN CONFERENCE
19h ago
moomoo
Analysis of Growth Drivers in the Biliary Tract Cancer Market
13h ago
Newsfilter
Three Key Sectors to Monitor While the S&P 500 Moves Sideways
17h ago
Barron's
PFIZER CEO ANNOUNCES COMPANY WILL LEAD IN TESTING ADVANCED STRATEGIES TO OPTIMIZE OBESITY PORTFOLIO - TD COWEN CONFERENCE
20h ago
moomoo
PFIZER CEO ANTICIPATES DOUBLE-DIGIT GROWTH FOR NEWLY LAUNCHED PRODUCTS THIS YEAR - TD COWEN CONFERENCE
20h ago
moomoo
Key Wall Street Rating Changes on Monday
21h ago
CNBC
Regencell Bioscience's 21,000% Stock Surge: Analyzing the Risks
1d ago
Fool
Regencell Bioscience's Performance Baffles Investors
1d ago
NASDAQ.COM
Eli Lilly Leads in GLP-1 Weight Loss Drug Market
1d ago
NASDAQ.COM
Eli Lilly's GLP-1 Drugs Show Rapid Growth Amid Concerns
2d ago
Fool
Astellas Reports Consistent Safety Profile for Perioperative Enfortumab Vedotin and Pembrolizumab in EV-304 Study
3d ago
moomoo
Novavax Q4 Revenue Surges 67% Amid Strategic Shift
4d ago
stocktwits
FDA Launches Bonus Scheme for Early Drug Review Completion
4d ago
seekingalpha
Wall Street Analysts Adjust Ratings
4d ago
Benzinga
Wall Street Analysts Adjust Ratings
4d ago
Benzinga
Show More News